BioCentury
ARTICLE | Company News

Cantab, Xenova deal

April 9, 2001 7:00 AM UTC

XEN completed its previously announced acquisition of CTB upon the receipt of acceptances of the merger offer representing 73% percent of CTB's issued shares (see BioCentury, Feb. 26). ...